There are alot of angry investors here that sort a return on the...

There are alot of angry investors here that sort a return on the last capital raising that continue to hammer sentiment and relay their trust issues. As new investors come on board and consolidate the register seeking a huge discount to the prices of last year the company will be reborn leaner and simplified.

AHZ has under 600m shares on offer with large Top 10 holders - market cap of under $20MILL.

AHZ has huge potential within the TAVR space worth BILLIONS of $USD. It wouldn't surprise me if this ridiculously low market valuation of AHZ, with over 10 years of RnD ends up in a tug of war takeover or better still JV partner covering all the costs and paying AHZ a royalty as the TAVR business explodes !

Yesterdays announcement highlighting the EOA (Effective Orifice Area) really opens the doos for many new types of treatments, take spinal injuries for instance. Imagine being able to insert one of these small valves letting through 60% more volume than previously thought possible ???